Dr. Reddy's Laboratories Ltd filed its 6-K report for the quarter ended December 31, 2024, indicating total assets of approximately $5.6 billion and net profit of $484 million for the period. The filing also notes that cash and cash equivalents were $152 million and that the company experienced growth in revenues of approximately $2.8 billion, up from $2.4 billion year-over-year.